Phase III randomized trial comparing gefitinib to gefitinib with pemetrexed-carboplatin chemotherapy in patients with advanced untreated EGFR mutant non-small cell lung cancer (gef vs gef+C) - Noronha, V; Joshi, A; Patil, V M (J Clin Oncol, 2019)
, et al.